Teleflex resolves FDA concerns at Arrow subsidiary

[news]

<p>In its October 2007 warning letter, the FDA raised concerns about quality systems control measures, which occurred prior to Teleflex's $2 billion acquisition of Arrow, based in Reading, Pa., that same year .</p>

Read more...